ETR vs MXCT · P/E 28, rev $12.95B vs rev $38.6M
Entergy Corporation (ETR) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the ETR and MXCT stock pages for the full models.
Not investment advice.